Skip to main content
Clinical Trials/CTRI/2025/04/085416
CTRI/2025/04/085416Not yet recruitingNot Applicable

Evaluation of nebulised Dexmedetomidine to attenuate hemodynamic response to laryngoscopy and endotracheal intubation

Gandhi medical college1 site in 1 country96 target enrollmentStarted: February 5, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
96
Locations
1
Primary Endpoint
To evaluate the efficacy of nebulised Dexmedetomidine given pre- operatively to attenuate Hemodynamic response to laryngoscopy and Endotracheal intubation.

Study Overview

Brief Summary

Dexmedetomidine in various doses and routes has been studied such as intravenous, intranasal, intramuscular to decrease the hemodynamic response to laryngoscopy and Endotracheal intubation.

However,intravenous administration may cause bradycardia and hypotension and intranasal administration may be associated with irritation.

This studt is about how  Nebulised Dexmedetomidine may offer an alternative to both intravenous as well as intranasal routes of administration,since the drug deposition following nebulization takes place over nasal, buccal as well as respiratory mucosa.  The nasal mucosa accounts for 65% of the bioavailability of nebulised Dexmedetomidine,while buccal mucosa accounts for 82%.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Not Applicable

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients of ASA grade I and ASA grade II Age group
  • 60 years MPG I and II BMI less than 35.

Exclusion Criteria

  • Patient refusal Patients requiring more than 15 seconds for intubation or more than 1 attempts of Laryngoscopy Patients taking medicines that affect the heart rate such as clonidine,beta –blockers Patients undergoing emergency surgeries will be excluded from the study.

Outcomes

Primary Outcomes

To evaluate the efficacy of nebulised Dexmedetomidine given pre- operatively to attenuate Hemodynamic response to laryngoscopy and Endotracheal intubation.

Time Frame: Before laryngoscopy,After laryngoscopy,1 min,5 min,10 min After intubation

Secondary Outcomes

  • To calculate total amount of Propofol used during induction of General Anesthesia & Fentanyl during surgery(For Propfol at baseline & for Fentanyl after 1 hr to end of surgery)

Investigators

Sponsor
Gandhi medical college
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials